Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer

Completed · Phase 3

Conditions studied: Prostate Cancer

In brief

RATIONALE: Hormone therapy may be an effective treatment for prostate cancer. PURPOSE: Randomized phase III trial to evaluate the effectiveness of treatment with flutamide and suramin with or without hydrocortisone in men who have metastatic or recurrent prostate cancer.

Key facts

Study ID

NCT00002881

Run by

Eastern Cooperative Oncology Group

Starts

1996-10-01

Last updated by the study team

2010-11-09

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.